Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Surprising Variability in Tryptamine Profiles of Psilocybe cubensis Fruiting Bodies: Inter- and Intra-Strain Differences Across 14 Strains Cultivated Under Controlled ConditionsJournal of Fungi · 2026-07-01Community engagement as a foundation for implementation research for group psilocybin assisted therapy in New MexicoFrontiers in Public Health · 2026-06-16Effects of psilocybin on sleep quality and brain microstructure in chronic cluster headacheJournal of Psychopharmacology · 2026-05-28Psilocybin for Treatment-Resistant Depression: A Comprehensive Review of Mechanisms and Therapeutic PotentialDigital Showcase Research, Scholarship, & Creative Works (University of Lynchburg) · 2026-05-21The Use of Psilocybin for Managing Refractory Behavioral Health Conditions: A New and Promising ApproachDigital Showcase Research, Scholarship, & Creative Works (University of Lynchburg) · 2026-05-21Psilocybin-Assisted Therapy in the Management of Anxiety and Depression Among Cancer PatientsDigital Showcase Research, Scholarship, & Creative Works (University of Lynchburg) · 2026-05-21Rapid-acting interventions in treatment-resistant depression - a comparative review of esketamine and psilocybinJournal of Pre-Clinical and Clinical Research · 2026-05-11A128-Channel Wireless Wearable Myolink (W2 Myolink): Functional Characteristics and Multidisciplinary ExperimentsResearch Square · 2026-04-27Psilocybin acutely reduces low-frequency BOLD power and frequency-specific connectivitybioRxiv · 2026-04-12Psilocybin for Treatment of Prolonged Grief Disorder: An Open-Label Feasibility Study ProtocolPsychoactives · 2026-04-12PSilocybin for psYCHological and existential distress in PALliative care (PSYCHED-PAL): A single arm unblinded clinical trialPalliative Medicine · 2026-01-29Daily Administration of Psilocin Mucate (L-130) Produces a Favorable Safety Profile and Anxiolytic Effects in Rodents Exposed to Chronic Unpredictable Mild StressJournal of Psychoactive Drugs · 2026-01-01Correction: Characteristics and mental health of psychedelic mushroom and multi-psychedelic users relative to non-psychedelic users in American adults, 2020-2021.Frontiers in psychiatry · 2025-12-31Psilocybin Production With Genetically Modified Aspergillus nidulans Under Pressurized ConditionsBiotechnology and Bioengineering · 2025-12-29Psilocybin-assisted therapy for individuals with palliative care needs: A systematic review of safety and efficacy.Unknown journal · 2025-12-17Correction: Acute and long-term effects of psilocybin on energy balance and feeding behavior in mice.Unknown journal · 2025-11-05Microdosing psilocybin and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trialsNeuropharmacology · 2025-11-01Cognitive and subjective effects of psilocybin microdosing: Results from two double-blind placebo-controlled longitudinal trialsNeuropharmacology · 2025-10-16Neurobiological and Therapeutic Potential of Psilocybin in Psychiatric DisordersJournal of Pharma Insights and Research. · 2025-10-04Understanding psilocybin mushrooms and aiding in setting standards for a burgeoning industry in JamaicaPhytochemistry Letters · 2025-09-30Psilocybin-assisted therapy for treatment-resistant depression in the US: a model-based cost-effectiveness analysisTranslational Psychiatry · 2025-08-28Toward Standardized Products Containing Biomass of Psilocybe Cubensis FungiJournal of AOAC International · 2025-08-12Treatment with LSD and psilocybin at the department of psychiatry at Frederiksberg Hospital in Denmark from 1960 to 1973: an analysis of 324 casesNordic Journal of Psychiatry · 2025-07-09Molecular, haemodynamic and functional effects of LSD in the human brainmedRxiv · 2025-06-17Correction to: Unraveling psilocybin's therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression.Psychopharmacology · 2025-05-31Evaluating the effectiveness of psilocybin in alleviating distress among cancer patients: A systematic review.Unknown journal · 2025-04-21Synthesis and In Vitro Profiling of Psilocin Derivatives: Improved Stability and Synthetic PropertiesJournal of Medicinal Chemistry · 2025-03-19Psychedelic-assisted treatment for substance use disorder: A narrative systematic review.Unknown journal · 2025-01-29Uncovering Psychedelics: From Neural Circuits to Therapeutic Applications.Unknown journal · 2025-01-18Psilocybin alleviates high-glucose and high-lipid-induced skin aging in BJ5Ta fibroblastsBiochemistry and Cell Biology · 2024-12-31Characteristics and mental health of psychedelic mushroom and multi-psychedelic users relative to non-psychedelic users in American adults, 2020-2021.Frontiers in psychiatry · 2024-12-31High-quality draft genomes of ecologically and geographically diverse Psilocybe speciesMicrobiology Resource Announcements · 2024-12-26Masking Influences: A Systematic Review of Placebo Control and Masking in Psychedelic Studies.Unknown journal · 2024-11-05Optimized psilocybin production in tryptophan catabolism-repressed fungiMicrobial Biotechnology · 2024-10-31Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulation in healthy humansmedRxiv · 2024-09-21An estimate of the number of people with clinical depression eligible for psilocybin-assisted therapy in the United StatesPsychedelics. · 2024-09-12Psilocybin in pharmacotherapy of obsessive-compulsive disorder.Unknown journal · 2024-07-31Unraveling psilocybin’s therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depressionPsychopharmacology · 2024-07-03High Blood Pressure Among Psilocybin and Cannabis Consumers During the COVID-19 Pandemic: An Analysis of the COVID-19 Cannabis Health StudyDrug and Alcohol Dependence · 2024-06-30Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseasesUnknown journal · 2024-05-31Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases.Unknown journal · 2024-04-05Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditationScientific Reports · 2024-03-25Screening and confirmation of psilocin, mitragynine, phencyclidine, ketamine and ketamine metabolites by liquid chromatography-tandem mass spectrometry.Unknown journal · 2024-02-29Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative studyScientific Reports · 2024-02-04Effects of psilocybin and sleep quality on brain water diffusivity and microstructure in healthy individuals and chronic cluster headache patientsNeuroscience Applied · 2023-12-31Exploring the molecular basis of treatment-resistant depression: Discoveries from a rat model and psilocybin therapyNeuroscience Applied · 2023-12-31CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivityHeadache The Journal of Head and Face Pain · 2023-12-31The Psychedelic Future of Post-Traumatic Stress Disorder Treatment.Unknown journal · 2023-12-31Amygdala response to emotional faces following acute administration of psilocybin in healthy individualsNeuroscience Applied · 2023-12-29Psilocybin-induced changes in cerebral blood flow are associated with acute and baseline inter-individual differencesScientific Reports · 2023-10-13Functional imaging studies of acute administration of classic psychedelics, ketamine, and MDMA: Methodological limitations and convergent results.Unknown journal · 2023-10-04Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in ratsMolecular Psychiatry · 2023-08-31In silico characterization of the psilocybin biosynthesis pathwayComputational Biology and Chemistry · 2023-03-22Acute neurovascular effects of psilocybin administration in healthy humans: Implications for cerebral blood flow measurements using arterial spin labellingNeuroscience Applied · 2022-12-31UNCOVERING THE UNTAPPED POTENTIAL OF PSILOCYBIN THERAPY IN ALLEVIATING CANCER-RELATED DEPRESSION: AN URGENT CALL TO RE-EVALUATE TREATMENT STRATEGIES.Unknown journal · 2022-12-31Music programming for psilocybin-assisted therapy: Guided Imagery and Music-informed perspectives.Frontiers in Psychology · 2022-11-16Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.New England Journal of Medicine · 2022-10-31Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-16Acute and long-term effects of psilocybin on energy balance and feeding behavior in mice.Translational Psychiatry · 2022-08-10Psilocybin-induced reduction in chronic cluster headache attack frequency correlates with changes in hypothalamic functional connectivitymedRxiv · 2022-07-09Effects of the 5-HT2A receptor antagonist volinanserin on head-twitch response and intracranial self-stimulation depression induced by different structural classes of psychedelics in rodents.Unknown journal · 2022-03-01Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulatory effects in healthy humansNeuroscience Applied · 2021-12-31Effects of psilocybin in relative and global cerebral blood flow and behavioural correlatesNeuroscience Applied · 2021-12-31The economics of psychedelic-assisted therapies: A research agenda.Frontiers in psychiatry · 2021-12-31Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study.Journal of Psychopharmacology · 2021-12-16Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history.Unknown journal · 2021-12-15Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience.European Neuropsychopharmacology · 2021-07-07Microdosing psychedelics and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trialsPsyArXiv · 2021-06-13Effects of psilocybin microdosing on awe and aesthetic experiences: a preregistered field and lab-based study.Psychopharmacology · 2021-04-29Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experiencebioRxiv · 2021-02-04P.227 Psilocybin induces resting-state functional connectivity changes, which correlate with plasma psilocin levels and psychedelic experienceEuropean Neuropsychopharmacology · 2020-10-31Scalable Hybrid Synthetic/Biocatalytic Route to PsilocybinChemistry - A European Journal · 2020-02-25Drugs and the Music Industry: How the Neurological and Visual Effects of LSD and Psilocybin Impact Creativity and Songwriting AbilitiesVCU Scholars Compass (Virginia Commonwealth University) · 2019-12-31Psilocybin may help cancer patients with depression and anxiety for yearsAccess Science · 2019-12-31Structure Based Drug Design towards Exploring Potential Anti-Psychotic and Anti-Depressant Activity of Possible Stiff Base of PsilocybinSSRN Electronic Journal · 2019-12-29The effects of psilocybin microdosing on perception: a double-blind controlled studyOSF Preprints (OSF Preprints) · 2019-01-30Intensity of Mystical Experiences Occasioned by 5-MeO-DMT and Comparison With a Prior Psilocybin Study.Frontiers in Psychology · 2018-12-05Mikrodosering av lysergsyradietylamid och psilocybin och dess effekter på psykisk hälsaKTH Publication Database DiVA (KTH Royal Institute of Technology) · 2017-12-31Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow.NeuroImage · 2017-07-11LSD treatment in Scandinavia: emphasizing indications and short-term treatment outcomes of 151 patients in Denmark.Nordic Journal of Psychiatry · 2017-07-04Indoleamine Hallucinogens in Cluster Headache: Results of the Clusterbusters Medication Use Survey.Journal of Psychoactive Drugs · 2015-11-22Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis.Psychopharmacology · 2008-05-17Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis.Journal of Psychopharmacology · 2007-04-30Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers.Pharmacopsychiatry · 2005-10-31529 The hallucinogen psilocybin increases prepulse inhibition of the startle reflex in healthy humansInternational Journal of Psychophysiology · 1998-08-31Effects of psychodysleptic drug psilocybin on visual perception. Changes in brightness preference.Unknown journal · 1969-01-31Psilocybin-induced Autonomic, Perceptual, and Behavioral ChangePharmacopsychiatry · 1968-10-31PSILOCYBIN-INDUCED CHANGES IN PSYCHOLOGIC FUNCTION, ELECTROENCEPHALOGRAM, AND LIGHT-EVOKED POTENTIALS IN HUMAN SUBJECTSMayo Clinic Proceedings · 1968-02-29Psilocybin-induced changes in psychologic function, electroencephalogram, and light-evoked potentials in human subjects.Unknown journal · 1968-02-29